March 06, 2024
2 min watch
Save
VIDEO: Iyuzeh reduces risk of inducing dry eye when treating glaucoma
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Renee Bovelle, MD, discusses the benefits of using Iyuzeh to treat glaucoma while not inducing dry eye.
Iyuzeh (Thea Pharma) is a preservative-free formulation of latanoprost to reduce elevated IOP in patients with open-angle glaucoma or ocular hypertension.
“This drug gives us the opportunity to prevent preservative-induced ocular surface disease while at the same time treating glaucoma,” Bovelle said. “With Iyuzeh, you have excellent access to care and your patients can get good coverage, reduce their IOP and not trade one problem for another.”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Healio could not confirm relevant financial disclosures at the time of publication.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.